A 50-year-old man is more likely to die from complications of a bone fracture than prostate cancer. Yet only 2% of older men ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.